|
Stocks
More News
Bristol-Myers Upgraded
May 22, 2013
Citigroup analyst Andrew S. Baum upgraded Bristol-Myers Squibb Co. (NYSE: BMY) to a Buy rating saying that the biopharmaceutical's cancer drug Nivolumab may be approved in early 2014 sending the stock... Read More
about
BMY
Saks Hires Goldman Sachs
May 22, 2013
Saks Inc. (NYSE: SKS) retained the services of Goldman Sachs to explore strategic alternatives including a possible sale. The stock price soared $1.83 to close at $15.50.... Read More
about
SKS
Most Active Stocks
Full List
Gainers (% change)
Full List
|
Latest Tweets
Popular Stocks
Full List
|